Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;15(3):349.
doi: 10.1007/s11481-020-09940-9. Epub 2020 Sep 2.

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review

Affiliations
Comment

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review

Tejas K Patel et al. J Neuroimmune Pharmacol. 2020 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Mehra MR, Desai SS, Ruschitzka F, Patel AN (2020a) Retraction- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. [published online ahead of print, 2020 May 22] [retracted in: Lancet. 2020 Jun 5;:null]. Lancet. S0140-6736(20)31180–31186. 10.1016/S0140-6736(20)31180-6
    1. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN (2020b) Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 10.1056/NEJMoa2007621 [published online ahead of print, 2020 Jun 4] [retraction of: N Engl J Med. 2020 May 1;:]. N Engl J Med. NEJMc2021225. 10.1056/NEJMc2021225 - PMC - PubMed
    1. Patel TK, Barvaliya M, Kevadiya BD, Patel PB, Bhalla HL (2020) Does adding of Hydroxychloroquine to the standard care provide any benefit in reducing the mortality among COVID-19 patients?: a systematic review. J NeuroImmune Pharmacol:1–9. 10.1007/s11481-020-09930-x - PMC - PubMed

LinkOut - more resources